中国冶金工业医学杂志

间歇性与持续性雄激素阻断治疗晚期前列腺癌临床分析

分类号：中图分类号：R 73725文献标志码：A文章编号：1005-5

出版年,卷(期):页码：2013,30(6):628-630

摘要：

摘要：目的探讨最大限度雄激素阻断（MAB）和间歇内分泌疗法（IHT）治疗晚期前列腺癌的疗效及副作用，为临床治疗晚期前列腺癌提供依据。方法2006年1月至2010年1月我院共收治晚期前列腺癌患者90例，其中48例予比卡鲁胺联合手术去势的MAB治疗、42例予戈舍瑞林联合比卡鲁胺行IHT治疗。结果与MAB疗法相比，IHT疗法副作用小，治疗间歇期未加重肿瘤进展。结论IHT疗法与MAB疗法治疗晚期前列腺癌的疗效无统计学差异，而IHT疗法安全、可行、副作用小，可作为雄激素依赖性晚期前列腺癌内分泌治疗的首选。

Abstract:ObjectiveTo evaluate the efficacy and side effect on the maximum androgen blockade(MAB)and intermittent hormonal therapy(IHT)in patient with advanced prostate cancer and Provide a theoretical basis and experimental basis for the treatment of advanced prostate cancerMethods90 cases of advanced prostate cancer patients between 48 patients who were taken MAB treatment and 42 patients who were taken IHT treatmentResultsThrough the comparison with the MAB treatment IHT treatment side effects is small,the treatment of intermittent period did not increase tumor progressionConclusionIn advanced prostate cancer,compared with the group subjects who were taken surgical castration combined with Bicalutamide for maximum androgen blockage(MAB),the treatment effect not worse than the patients who were taken intermittent hormonal therapy（IHT）combined with goserelin and Bicalutamidethe intermittent hormonal therapy（IHT）is safety and feasibleThus,IHT for androgen-dependent advanced prostate cancer will be a first line of treatment choice

基金项目：

作者简介：

参考文献：

[1]Reid AH,Attard G,Danila DC,et al.Significant and sustained antitumor activity in post-docetaxel,castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate[J].J Clin Oncol，2010，28(9)：1489-1495.

[2]Leeuwen PJ,Bergh RC,Wolters T,et al.Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality[J].Can J Urol， 2011 ，18(6)：6018-6024.

[3]Liu X,Choi RY,Jawad SM,et al.Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells[J].Prostate， 2011，71(7)：766-777.

[4]Giesing M,Suchy B,Driesel G,et al.Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy[J].BJU Int，2010，105(7)：1000-1010.

服务与反馈：

【文章下载】【加入收藏】